The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia (POST)
The Paliperidone ER Outcomes Study of Schizophrenia Patients in Typical Clinical Practice
Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC
Terminated
The study was terminated because it was not enrolling at the expected rate
Other terminated trials from Ortho-McNeil Janssen Scientific Affairs, LLC
More terminations from Ortho-McNeil Janssen Scientific Affairs, LLC
Listed as NCT00488891, this observational or N/A phase trial focuses on Schizophrenia and remains terminated or withdrawn. Sponsored by Ortho-McNeil Janssen Scientific Affairs, LLC, it has been updated 10 times since 2007, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
-
Nov 2020 — Jan 2021 [monthly]
Terminated
▶ Show 5 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Terminated
-
May 2018 — Jun 2018 [monthly]
Terminated
-
Apr 2018 — May 2018 [monthly]
Terminated
Phase: PHASE4 → None
-
Aug 2017 — Apr 2018 [monthly]
Terminated PHASE4
-
Jan 2017 — Aug 2017 [monthly]
Terminated PHASE4
First recorded
Apr 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ortho-McNeil Janssen Scientific Affairs, LLC
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.